1. Leier Carl V
2. Haas Garrie J
3. Binkley Philip F

9789350258798

10.5005/jp/books/11766_2

1/e

2013

38

1. Davis heart Lung research Institute, Th e Ohio State University of Medicine and public health, Columbus, Ohio, USA, Davis Heart Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA, The Ohio State University College of Medicine, Columbus, Ohio, USA
2. Davis heart and Lung research Institute, The Ohio State University of Medicine and public health, Columbus, Ohio, USA, Davis Heart Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA, The Ohio State University of Medicine and Public Health, Davis Heart and Lung Research Institute, Columbus, Ohio, USA
3. The Ohio State University, Columbus, Ohio, USA, Davis Heart Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA, Davis Heart and Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA

positive inotropic drugs, cardiomyocyte, coronary artery disease, oxygen metabolic supply, dobutamine, coronary obstructing lesions, adrenergic agents